Zdrowie i gospodarka · 07/10/2022
FDA Announces Fee Rate for Using Priority Review Voucher in FY 2023
The US Food and Drug Administration (FDA) has set the fee rate for using a priority review voucher for fiscal year 2023, which is based on the average cost of reviewing priority review applications versus non-priority review applications from the previous year.
Source: Federal Register — Food and Drug AdministrationOpen original release →